Multi-omics identifies severe asthma endotypes linked to Streptococcus dysbiosis and lipid metabolic dysregulation
Open Access
- 16 October 2025
- journal article
- Published by Elsevier in World Allergy Organization Journal
- Vol. 18 (11) , 101132
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2023YFF1203800)
- National Natural Science Foundation of China (81960023)
- Guangzhou Medical University (GMUCR2024-02009)
- Guangzhou Medical University (GMUCR2025-02014)
- Natural Science Foundation of Guangdong Province (2024A1515012830)
- Natural Science Foundation of Guangdong Province (2023A1515012917)
This publication has 40 references indexed in Scilit:
- Clinical and transcriptomic features of persistent exacerbation‐prone severe asthma in U‐BIOPRED cohortClinical and Translational Medicine, 2022
- Lipid metabolism and identification of biomarkers in asthma by lipidomic analysisBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2021
- Managing Asthma in Adolescents and AdultsJAMA, 2020
- Serum-borne lipids amplify TLR-activated inflammatory responsesJournal of Leukocyte Biology, 2020
- Epithelial barriers in allergy and asthmaJournal of Allergy and Clinical Immunology, 2020
- Dysbiosis of the gut and lung microbiome has a role in asthmaSeminars in Immunopathology, 2020
- Nucleic Acid Sensing in Allergic Disorders2019
- Airway Microbial Diversity is Inversely Associated with Mite-Sensitized Rhinitis and Asthma in Early ChildhoodScientific Reports, 2017
- Asthma Metabolomics and the Potential for Integrative Omics in Research and the ClinicChest, 2017
- FLASH: fast length adjustment of short reads to improve genome assembliesBioinformatics, 2011